Back to BNP PARIBAS FINANCIAL MARKETS BNP PARIBAS FINANCIAL MARKETS

EGRXEGRX
25 quarters

Position history for BNP PARIBAS FINANCIAL MARKETSBNP PARIBAS FINANCIAL MARKETS's holdings in EAGLE PHARMACEUTICALS INC

BNP PARIBAS FINANCIAL MARKETS previously held 0 shares of EGRX (EAGLE PHARMACEUTICALS INC), worth $0 as of 2024-Q4.

Final Value

$0

Final Shares

0

Total Value Change

-$16,237

Total Shares Change

-403

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2024-Q4
Latest
Exited
0
-100.0%
$00.0%$0.50
0
2024-Q3
Decreased
17,976
-26.3%
$67,0500.0%$3.95
0
2024-Q2
Decreased
24,402
-34.7%
$136,6510.0%$5.60
0
2024-Q1
Decreased
37,385
-57.9%
$195,8970.0%$5.24
0
2023-Q4
Increased
88,685
+378.7%
$463,8230.0%$5.23
39
2023-Q3
Decreased
18,527
-56.9%
$292,1710.0%$15.77
0
2023-Q2
Increased
43,019
+121.2%
$836,2890.0%$19.47
40
2023-Q1
Decreased
19,446
-22.4%
$551,6830.0%$27.88
0
2022-Q4
Increased
25,050
+7.5%
$732,2120.0%$29.23
27
2022-Q3
Increased
23,296
+637.2%
$615,4800.0%$28.60
39
2022-Q2
Decreased
3,160
-14.9%
$140,3990.0%$43.12
0
2022-Q1
Decreased
3,712
-42.0%
$183,7070.0%$49.50
0
2021-Q4
Decreased
6,397
-45.8%
$325,7350.0%$51.10
0
2021-Q3
Increased
11,793
+171.0%
$657.8M0.0%$55.09
51
2021-Q2
Increased
4,351
+94.2%
$186,2230.0%$42.14
36
2021-Q1
Increased
2,240
+20.9%
$93,4980.0%$41.06
26
2020-Q4
Decreased
1,852
-38.3%
$86,2480.0%$46.50
0
2020-Q3
Increased
3,002
+67.4%
$127,5250.0%$41.88
33
2020-Q2
Decreased
1,793
-91.8%
$86,0280.0%$48.02
0
2020-Q1
Increased
21,986
+840.8%
$1M0.0%$45.31
40
2019-Q4
Decreased
2,337
-88.1%
$140,4070.0%$59.89
0
2019-Q3
Increased
19,616
+2.3%
$1.1M0.0%$56.43
26
2019-Q2
Increased
19,185
+637.3%
$1.1M0.0%$55.68
41
2019-Q1
Increased
2,602
+545.7%
$131,3750.0%$50.49
36
2018-Q4
New
403
-
$16,2370.0%$39.23
28

Other major holders of EGRX: Janus Henderson Group Ltd.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used